Abstract
The primary study objective was to assess the safety of a low-dose levonorgestrel intrauterine contraceptive system (LNG-IUS13.5mg; Skyla® in the US, Jaydess® elsewhere) in adolescents (presented previously[Gemzell-Danielsson et al. Fertil Steril 2014;102:e12-13]). Here, we evaluate ease of placement and placement-related pain, bleeding profile and dysmenorrhea.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
